AU2002340785A1 - Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides - Google Patents

Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides

Info

Publication number
AU2002340785A1
AU2002340785A1 AU2002340785A AU2002340785A AU2002340785A1 AU 2002340785 A1 AU2002340785 A1 AU 2002340785A1 AU 2002340785 A AU2002340785 A AU 2002340785A AU 2002340785 A AU2002340785 A AU 2002340785A AU 2002340785 A1 AU2002340785 A1 AU 2002340785A1
Authority
AU
Australia
Prior art keywords
polypeptides
pharmaceutical composition
aprotinin
factor vii
vii polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002340785A
Inventor
Rasmus Rojkjaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2002340785A1 publication Critical patent/AU2002340785A1/en
Abandoned legal-status Critical Current

Links

AU2002340785A 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides Abandoned AU2002340785A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101668 2001-11-09

Publications (1)

Publication Number Publication Date
AU2002340785A1 true AU2002340785A1 (en) 2003-05-19

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002351755A1 (en) Liquid composition of modified factor vii polypeptides
HUP0500989A2 (en) Animicrobial polypeptides and their uses
AU2002336919A1 (en) Human coagulation factor vii polypeptides
HUP0400976A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
EP1462455A4 (en) Novel peptides and medicinal uses thereof
AU2002354062A1 (en) Sealing composition and sealing material
WO2002072030A8 (en) High affinity integrin polypeptides and uses thereof
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
EP1379228A4 (en) (z)-styrylbenzylsulfones and pharmaceutical uses thereof
IL161544A0 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU2002340785A1 (en) Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides
IL161523A0 (en) Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
AU2001280464A1 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002340781A1 (en) Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides
AU2002340784A1 (en) Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides
AU2002340777A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2002350423A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
AU2002351714A1 (en) Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid
AU2002340782A1 (en) Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors
AU2002340780A1 (en) Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors
AUPR589701A0 (en) Novel peptide and use thereof